This is one of the most exciting times in headache medicine, with many new migraine-specific biologics available for both acute and preventive treatment. Migraine is a central nervous system disease that is both prevalent and disabling. In individuals age 15-49, it is the second leading cause of years lived with disability.1 The prevalence is 12% in the general population.2 ... Continue Reading
Migraine-Specific Biologics Now Available for Treatment of Headache
By Aliza S. Kumpinsky, MD